The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites

Molecular Microbiology

Volumn 81, Issue 1, 2011, Pages 143-156

  Strotmeier, Jasmin ^a   Gu, Shenyan ^b   Jutzi, Stephan ^a   Mahrhold, Stefan ^a   Zhou, Jie ^b   Pich, Andreas ^a   Eichner, Timo ^c   Bigalke, Hans ^a   Rummel, Andreas ^a   Jin, Rongsheng ^b   Binz, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN B; BOTULINUM TOXIN C; BOTULINUM TOXIN G; GANGLIOSIDE; SIALIC ACID; SYNAPTOTAGMIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; CRYSTAL STRUCTURE; GANGLIOSIDE BINDING SITE; HEMIDIAPHRAGM; MOUSE; NEUROTOXICITY; NONHUMAN; PHRENIC NERVE; PRIORITY JOURNAL; RAT; SYNAPTIC MEMBRANE;

ANIMALS; BINDING SITES; BOTULINUM TOXINS; CRYSTALLOGRAPHY, X-RAY; DIAPHRAGM; MICE; MODELS, MOLECULAR; N-ACETYLNEURAMINIC ACID; PHRENIC NERVE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

MUS;

EID: 79959549721     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2011.07682.x     Document Type: Article

References (62)

1. Adams, P.D., Afonine, P.V., Bunkoczi, G., Chen, V.B., Davis, I.W., Echols, N., etal. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213-221.
2. Binz, T., and Rummel, A. (2009) Cell entry strategy of clostridial neurotoxins. J Neurochem 109: 1584-1595.
3. Blasi, J., Chapman, E.R., Yamasaki, S., Binz, T., Niemann, H., and Jahn, R. (1993) Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J 12: 4821-4828.
4. Brunger, A.T. (1992) Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355: 472-475.
5. Chai, Q., Arndt, J.W., Dong, M., Tepp, W.H., Johnson, E.A., Chapman, E.R., and Stevens, R.C. (2006) Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Nature 444: 1096-1100.
6. Chen, C., Fu, Z., Kim, J.J., Barbieri, J.T., and Baldwin, M.R. (2009) Gangliosides as high affinity receptors for tetanus neurotoxin. J Biol Chem 284: 26569-26577.
7. Davis, I.W., Leaver-Fay, A., Chen, V.B., Block, J.N., Kapral, G.J., Wang, X., etal. (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35: W375-W383.
8. Dong, M., Richards, D.A., Goodnough, M.C., Tepp, W.H., Johnson, E.A., and Chapman, E.R. (2003) Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J Cell Biol 162: 1293-1303.
9. Dong, M., Yeh, F., Tepp, W.H., Dean, C., Johnson, E.A., Janz, R., and Chapman, E.R. (2006) SV2 is the protein receptor for botulinum neurotoxin A. Science 312: 592-596.
10. Dong, M., Tepp, W.H., Liu, H., Johnson, E.A., and Chapman, E.R. (2007) Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons. J Cell Biol 179: 1511-1522.
11. Dong, M., Liu, H., Tepp, W.H., Johnson, E.A., Janz, R., and Chapman, E.R. (2008) Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol Biol Cell 19: 5226-5237.
12. Eleopra, R., Tugnoli, V., Rossetto, O., Montecucco, C., and De Grandis, D. (1997) Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human. Neurosci Lett 224: 91-94.
13. Emsley, P., and Cowtan, K. (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132.
14. Emsley, P., Fotinou, C., Black, I., Fairweather, N.F., Charles, I.G., Watts, C., etal. (2000) The structures of the H(C) fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding. J Biol Chem 275: 8889-8894.
15. Foran, P., Lawrence, G.W., Shone, C.C., Foster, K.A., and Dolly, J.O. (1996) Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. Biochemistry 35: 2630-2636.
16. Fotinou, C., Emsley, P., Black, I., Ando, H., Ishida, H., Kiso, M., etal. (2001) The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin. J Biol Chem 276: 32274-32281.
17. Fu, Z., Chen, C., Barbieri, J.T., Kim, J.J., and Baldwin, M.R. (2009) Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Biochemistry 48: 5631-5641.
18. Gronborg, M., Pavlos, N.J., Brunk, I., Chua, J.J., Munster-Wandowski, A., Riedel, D., etal. (2010) Quantitative comparison of glutamatergic and GABAergic synaptic vesicles unveils selectivity for few proteins including MAL2, a novel synaptic vesicle protein. J Neurosci 30: 2-12.
19. Habermann, E., Dreyer, F., and Bigalke, H. (1980) Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum A toxin. Naunyn Schmiedebergs Arch Pharmacol 311: 33-40.
20. Hayward, S., and Berendsen, H.J. (1998) Systematic analysis of domain motions in proteins from conformational change: new results on citrate synthase and T4 lysozyme. Proteins 30: 144-154.
21. Herreros, J., Lalli, G., and Schiavo, G. (2000) C-terminal half of tetanus toxin fragment C is sufficient for neuronal binding and interaction with a putative protein receptor. Biochem J 347 (Part 1): 199-204.
22. Herreros, J., Ng, T., and Schiavo, G. (2001) Lipid rafts act as specialized domains for tetanus toxin binding and internalization into neurons. Mol Biol Cell 12: 2947-2960.
23. van Heyningen, W.E., and Miller, P.A. (1961) The fixation of tetanus toxin by ganglioside. J Gen Microbiol 24: 107-119.
24. Jaques, L.W., Brown, E.B., Barrett, J.M., and Brey, W.S.J.W.W., Jr (1977) Sialic acid. A calcium-binding carbohydrate. J Biol Chem 252: 4533-4538.
25. Jayaraman, S., Eswaramoorthy, S., Kumaran, D., and Swaminathan, S. (2005) Common binding site for disialyllactose and tri-peptide in C-fragment of tetanus neurotoxin. Proteins 61: 288-295.
26. Jin, R., Rummel, A., Binz, T., and Brunger, A.T. (2006) Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature 444: 1092-1095.
27. Kabsch, W., and Sander, C. (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22: 2577-2637.
28. Karalewitz, A.P., Kroken, A.R., Fu, Z., Baldwin, M.R., Kim, J.J., and Barbieri, J.T. (2010) Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA. Biochemistry 49: 8117-8126.
29. Kawai, H., Allende, M.L., Wada, R., Kono, M., Sango, K., Deng, C., etal. (2001) Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem 276: 6885-6888.
30. Kitamura, M., Takamiya, K., Aizawa, S., and Furukawa, K. (1999) Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice. Biochim Biophys Acta 1441: 1-3.
31. Koriazova, L.K., and Montal, M. (2003) Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat Struct Biol 10: 13-18.
32. Kumaran, D., Eswaramoorthy, S., Furey, W., Navaza, J., Sax, M., and Swaminathan, S. (2009) Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation. J Mol Biol 386: 233-245.
33. McCoy, A.J., Grosse-Kunstleve, R.W., Adams, P.D., Winn, M.D., Storoni, L.C., and Read, R.J. (2007) Phaser crystallographic software. J Appl Cryst 40: 658-674.
34. Mahrhold, S., Rummel, A., Bigalke, H., Davletov, B., and Binz, T. (2006) The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett 580: 2011-2014.
35. Montal, M. (2010) Botulinum neurotoxin: a marvel of protein design. Annu Rev Biochem 79: 591-617.
36. Montecucco, C. (1986) How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem Sci 11: 314-317.
37. Munro, P., Kojima, H., Dupont, J.L., Bossu, J.L., Poulain, B., and Boquet, P. (2001) High sensitivity of mouse neuronal cells to tetanus toxin requires a GPI-anchored protein. Biochem Biophys Res Commun 289: 623-629.
38. Muraro, L., Tosatto, S., Motterlini, L., Rossetto, O., and Montecucco, C. (2009) The N-terminal half of the receptor domain of botulinum neurotoxin A binds to microdomains of the plasma membrane. Biochem Biophys Res Commun 380: 76-80.
39. Nishiki, T., Kamata, Y., Nemoto, Y., Omori, A., Ito, T., Takahashi, M., and Kozaki, S. (1994) Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J Biol Chem 269: 10498-10503.
40. Oguma, K., Yokota, K., Hayashi, S., Takeshi, K., Kumagai, M., Itoh, N., etal. (1990) Infant botulism due to Clostridium botulinum type C toxin. Lancet 336: 1449-1450.
41. Osen-Sand, A., Staple, J.K., Naldi, E., Schiavo, G., Rossetto, O., Petitpierre, S., etal. (1996) Common and distinct fusion proteins in axonal growth and transmitter release. J Comp Neurol 367: 222-234.
42. Otwinowski, Z., and Minor, W. (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276: 307-326.
43. Rummel, A., Bade, S., Alves, J., Bigalke, H., and Binz, T. (2003) Two carbohydrate binding sites in the H(CC)-domain of tetanus neurotoxin are required for toxicity. J Mol Biol 326: 835-847.
44. Rummel, A., Karnath, T., Henke, T., Bigalke, H., and Binz, T. (2004a) Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J Biol Chem 279: 30865-30870.
45. Rummel, A., Mahrhold, S., Bigalke, H., and Binz, T. (2004b) The Hcc-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction. Mol Microbiol 51: 631-643.
46. Rummel, A., Eichner, T., Weil, T., Karnath, T., Gutcaits, A., Mahrhold, S., etal. (2007) Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Proc Natl Acad Sci USA 104: 359-364.
47. Rummel, A., Hafner, K., Mahrhold, S., Darashchonak, N., Holt, M., Jahn, R., etal. (2009) Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor. J Neurochem 110: 1942-1954.
48. Schiavo, G., Shone, C.C., Bennett, M.K., Scheller, R.H., and Montecucco, C. (1995) Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J Biol Chem 270: 10566-10570.
49. Schiavo, G., Matteoli, M., and Montecucco, C. (2000) Neurotoxins affecting neuroexocytosis. Physiol Rev 80: 717-766.
50. Shields, G.C., Laughton, C.A., and Orozco, M. (1997) Molecular dynamics simulations of the d(T.A.T) triple helix. J Am Chem Soc 119: 7463-7469.
51. Simpson, L.L., and Rapport, M.M. (1971) The binding of botulinum toxin to membrane lipids: sphingolipids, steroids and fatty acids. J Neurochem 18: 1751-1759.
52. Stenmark, P., Dupuy, J., Imamura, A., Kiso, M., and Stevens, R.C. (2008) Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction. PLoS Pathog 4: e1000129.
53. Stenmark, P., Dong, M., Dupuy, J., Chapman, E.R., and Stevens, R.C. (2010) Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding. J Mol Biol 397: 1287-1297.
54. Strotmeier, J., Lee, K., Volker, A.K., Mahrhold, S., Zong, Y., Zeiser, J., etal. (2010) Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner. Biochem J 431: 207-216.
55. Swaminathan, S., and Eswaramoorthy, S. (2000) Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat Struct Biol 7: 693-699.
56. Takamori, S., Holt, M., Stenius, K., Lemke, E.A., Gronborg, M., Riedel, D., etal. (2006) Molecular anatomy of a trafficking organelle. Cell 127: 831-846.
57. Tsukamoto, K., Kohda, T., Mukamoto, M., Takeuchi, K., Ihara, H., Saito, M., and Kozaki, S. (2005) Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins. J Biol Chem 280: 35164-35171.
58. Tsukamoto, K., Kozai, Y., Ihara, H., Kohda, T., Mukamoto, M., Tsuji, T., and Kozaki, S. (2008) Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D. Microb Pathog 44: 484-493.
59. Vaidyanathan, V.V., Yoshino, K., Jahnz, M., Dorries, C., Bade, S., Nauenburg, S., etal. (1999) Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage. J Neurochem 72: 327-337.
60. Williamson, L.C., Halpern, J.L., Montecucco, C., Brown, J.E., and Neale, E.A. (1996) Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa. J Biol Chem 271: 7694-7699.
61. Williamson, L.C., Bateman, K.E., Clifford, J.C., and Neale, E.A. (1999) Neuronal sensitivity to tetanus toxin requires gangliosides. J Biol Chem 274: 25173-25180.
62. Wohlfarth, K., Goschel, H., Frevert, J., Dengler, R., and Bigalke, H. (1997) Botulinum A toxins: units versus units. Naunyn Schmiedebergs Arch Pharmacol 355: 335-340.